Protalix BioTherapeutics, Inc.

AMEX (USD): Protalix BioTherapeutics, Inc. (PLX)

Last Price

1.40

Today's Change

-0.01 (0.70%)

Day's Change

1.33 - 1.41

Trading Volume

327,256

Financial
Reported Currency in USD
Market Cap

Market Cap

102 Million

Shares Outstanding

73 Million

Latest Quarter

Latest Quarter

30-Sep-2024 [Q3]

Announcement Date

14-Nov-2024

Reported Currency

USD

Revenue QoQ | YoY

33.29% | 73.60%

NP QoQ | YoY

246.89% | 274.73%

Latest Annual

Latest Annual

31-Dec-2023

Announcement Date

14-Mar-2024

Reported Currency

USD

Revenue | Net Profit

65,494,000.00 | 8,312,000.00

EPS | EPS Diluted

0.12 Cent | 0.10 Cent

YoY

155.68%

NP Margin

12.69%

Discussions
Be the first to like this. Showing 3 of 3 comments

ysabag

with the new ceo it will raise above the target

2014-07-29 14:51

Tygobar

Yes, medical startups usually should very very good in everything like that really and totally , yet you do have very low price of the stock here, how can you really even describe this ? Could you damn let me know this please. I am all ears for example.

2019-09-01 13:12

Lalis

I do hope that medical things will be really our future and not just cause it cause something for example good for now, but in the real perspective for many many generations ahead totally. But for now of course I plan to invest a lot in such things.

2019-09-07 13:56

Post a Comment